Gilead is requiring 340B covered entities to supply claims data for its branded hepatitis C products to be able to continue to be eligible for bill to / ship to orders for multiple contract pharmacies.

News Alert

Gilead Announces 340B Contract Pharmacy Restrictions that Apply to Hospital and Grantee Entities

Gilead late yesterday imposed conditions on 340B pricing on its branded hepatitis C treatments when covered entities use contract pharmacies.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
×

*Sign up for news summaries and alerts from 340B Report